S03 E07
Surgibots Podcast

Pimp My Robot – How Ultrasonics Will Get Better Outcomes - Nico Fenu - Nami Surgical

Explore the applications of ultrasound in surgical robotics with your host, Henry Norton, and Nico Fenu, the Co-Founder and CEO of Nami Surgical. Nico explained the variety of ultrasound applications within the surgical robotics industry, from ultrasonic imaging to biopsies and precision surgery. He also explained the technical side of developing an ultrasound application, as well as Nami Surgical’s process of spinning out from a university research centre. Tune in to hear more about this exciting branch of surgical development.

Pimp My Robot – How Ultrasonics Will Get Better Outcomes - Nico Fenu - Nami Surgical

ALSO AVAILABLE ON

SpotifyApple podcastsAmazon music
Share
S03 E07

Pimp My Robot – How Ultrasonics Will Get Better Outcomes - Nico Fenu - Nami Surgical

The Future of Robotic Surgery: How Ultrasonics is Revolutionizing Surgical Innovation

In the ever-evolving landscape of medical technology, robotic surgery has made tremendous strides. A particularly exciting breakthrough in this field is the miniaturization of ultrasonic devices, allowing for greater precision, reduced trauma, and improved patient outcomes. In this article, we explore the insights from Nico Fenu, co-founder of Nami Surgical, a pioneering company in ultrasonic surgical robotics, and discuss how this technology is shaping the future of healthcare.

The Journey to Ultrasonics in Surgery

Nico Fenu’s Background and Discovery of Ultrasonics

Nico Fenu, a biomedical engineer from Italy, discovered his passion for ultrasonics during his master's degree in biomedical engineering. His work on an ultrasonic biopsy needle, which reduces trauma and improves surgical accuracy, sparked his interest in the field. During his PhD at the University of Glasgow, he began exploring ways to miniaturize ultrasonic instruments to make them more effective for robotic surgery.

The Impact of Ultrasonic Technology in Surgery

Ultrasonics utilizes high-frequency sound waves to interact with tissues in unique ways. Unlike traditional surgical tools, ultrasonic devices allow for non-invasive imaging, precise cutting, and tissue modification without excessive heat or electrical energy. These advantages make them particularly useful in robotic-assisted procedures.

The Challenges and Breakthroughs of Miniaturization

The Limitations of Conventional Ultrasonic Instruments

Traditionally, ultrasonic surgical instruments are constrained by size. The physics of sound waves means that larger instruments are needed to produce the necessary frequencies for effective cutting and coagulation. This poses a challenge for robotic surgery, where instruments must be compact and maneuverable.

Nami Surgical’s Breakthrough: Miniaturization of Ultrasonic Devices

Nami Surgical, founded by Nico Fenu and Dr. Rebecca Cleary, has developed a novel approach to overcoming these limitations. Their technology modifies the structure of the transducer, enabling it to maintain efficiency even at a smaller size. This innovation allows ultrasonic devices to be used in robotic-assisted surgeries, providing surgeons with greater dexterity and precision.

The Clinical Benefits of Ultrasonics in Robotic Surgery

Enhanced Surgical Precision and Safety

Miniaturized ultrasonic devices offer several advantages:

  • Reduced thermal spread: Unlike electrocautery, which generates excessive heat, ultrasonics provides controlled energy delivery, minimizing damage to surrounding tissues.
  • More precise tissue dissection: The ability to finely control vibrations allows for cleaner cuts, which is crucial for delicate surgeries such as tumor resections.
  • Improved coagulation: Ultrasonic instruments can cut and coagulate simultaneously, reducing blood loss and surgical time.

Shorter Hospital Stays and Faster Recovery

With increased precision and reduced trauma, patients benefit from:

  • Less postoperative pain
  • Lower risk of complications
  • Shorter hospital stays
  • Faster recovery times

The Business Journey: From Research to Commercialization

Overcoming the Challenges of Medical Device Commercialization

Bringing a medical device to market is a complex process requiring extensive research, regulatory approvals, and strategic partnerships. Fenu’s journey involved extensive market research and collaboration with industry leaders to refine the product and validate its commercial potential.

Securing Investment and Building a Team

Nami Surgical successfully secured funding through grants and private investors, raising over £3.5 million. The company has grown into a team of 15 professionals, including engineers, business strategists, and medical advisors, all working towards making ultrasonic robotic surgery a reality.

The Future of Ultrasonic Robotic Surgery

Expanding the Applications of Miniaturized Ultrasonic Devices

While the primary focus remains on surgical robotics, the miniaturization of ultrasonic technology has potential applications in:

  • Non-invasive imaging
  • Underwater acoustics and sonar systems
  • Jet engine maintenance and repair

Commercialization Strategy and Market Entry

Nami Surgical aims to integrate its technology into existing robotic surgical platforms through strategic partnerships. By licensing its innovations to established medical device manufacturers, the company seeks to bring its technology to operating rooms worldwide by 2027.

Advice for Future Innovators in Medical Technology

Key Lessons from Nico Fenu

For aspiring biomedical entrepreneurs, Fenu offers valuable advice:

  • Listen and learn: Engaging with industry experts and potential customers is crucial for refining an idea.
  • Protect your intellectual property: Secure patents before revealing technical details to investors or competitors.
  • Find the right investors: Look for partners who align with your vision and can provide more than just financial support.
  • Stay persistent: The journey from research to commercialization is challenging, but perseverance is key to success.

Final Thoughts

The future of robotic surgery is being shaped by groundbreaking advancements in ultrasonic technology. Through innovation and persistence, Nami Surgical is leading the way in making surgeries safer, more efficient, and more accessible. As this technology continues to evolve, it has the potential to revolutionize not only surgical procedures but also a wide range of industries that rely on precision engineering.

LISTEN ON YOUR FAVOURITE PODCAST PLATFORM
SpotifyApple podcastsAmazon music

More episodes in this industry

What's the Hype with Neuro? A Lesson in the Brain - With Hannah Claridge
Podcast43

What's the Hype with Neuro? A Lesson in the Brain - With Hannah Claridge

In this episode, your host, Henry Norton, is joined by Hannah Claridge, the Head of Neurotechnology at TTP, to talk about the incredible advancements that are being made to treat neurological conditions. Hannah points out how complex the brain and nervous systems are, with both relying on intricate connections. She also explores the new technologies that are being developed to treat nervous disorders, such as spinal cord stimulation. She also compared neurotechnologies to pharmaceuticals, highlighting the parallels and differences in how they interact with the body. Hannah also suggested that neurotherapy will be key to the advancement of treatments for conditions like depression, due to their ability to provide targeted and long-term relief of symptoms. Cybersecurity is also a major concern for neurotechnology, as any malfunction or deliberate interference could have serious ramifications for patients.
Why Most Medtech Fundraisers Fail and What to Do Instead - Kiko Filipov, Partner at APPARIUS
Podcast42

Why Most Medtech Fundraisers Fail and What to Do Instead - Kiko Filipov, Partner at APPARIUS

Raising capital in Medtech is tougher than ever. Investor expectations have shifted. Competition is up. And many founders are still pitching like it’s 2018. In this episode, Henry Norton sits down with Kiko Filipov, Partner at APPARIUS Corporate Finance and Strategic Advisor at Cruxx, to unpack the real mechanics of a successful fundraise in 2025. From first-in-human data to commercial readiness, Kiko shares what separates the rounds that get oversubscribed from the ones that stall. He also explores the changing landscape of Medtech innovation and why strategic exits take years of planning, how emerging markets are joining the race, and where VCs are placing bets across surgical robotics, neurostimulation, and digital health. Whether you're gearing up for Series A or preparing your pitch deck, this episode delivers tactical clarity from someone who’s in the room with both founders and funds.

Discover more about Medical Devices